Research has suggested that bacteriophages derived and manipulated from ExPEC reservoirs are capable of combating infections caused by E.coli ‘superbugs’.
Browsing: Clinical > Antimicrobial Resistance
This study delves aims to evaluate the efficacy of durancin 61A as an inhibitor of resistant clinical pathogens and to shed light on its mode of action.
This editorial presents some of the latest evidence to support the antivirulence approach, highlighting at the same time some of the issues that need to be considered when evaluating antivirulence drugs.
In this podcast Dr Elizabeth Whittaker, Dr James Seddon, Dr Pete Dodd and Professor Beate Kampmann discuss their work in pediatric tuberculosis focusing on the areas of immunology, modelling and drug resistance.
Take a look at our new infographic, developed for World Tuberculosis Day, which explores the facts about current TB burden, the issues around drug resistance, and research and development moving forwards.
In this original research article, the authors determine the structural contributions of a compound set containing inhibitors of bacterial enzyme FabI.
With TB still presenting a major health problem across the globe, we spoke to Timothy Rodwell about the challenges currently facing TB diagnostics and his work as acting head of the TB Program at FIND.